FRC
FRC Logo
Sign InGet Access

Connect With Us

Stay updated with our latest research and insights

Fundamental Research Corp Logo

Highly ranked equity research firm providing institutional grade tools and analysis to all investors worldwide. Trusted by global investors for over 20+ years.

20+ Years

Policies

  • Privacy Policy
  • Terms of Service
  • Disclaimer

Company

  • About Us
  • Our Team
  • Contact Us

Resources

  • Videos
  • Research Reports
  • FAQ

© 2026 Fundamental Research Corp. All Rights Reserved.

Professional investment research since 2003

Home
Research
Get Access
Sign In
Bonesupport Holding AB (publ) Stock AnalysisComprehensive stock analysis for Bonesupport Holding AB (publ) (BOEUF) including live price, Snowflake performance metrics, financial statements, and investment research.Stock AnalysisBOEUF
BOEUF
Bonesupport Holding AB (publ)
  • Company Overview
  • FRC Research
  • Financial Data
  • Peer Comparison
  • Ownership & News
BOEUF
Home🔹Stocks🔹Bonesupport Holding AB (publ)

Bonesupport Holding AB (publ)

BOEUF•OTC

Bonesupport Holding AB (publ)

BOEUF•OTC
Market cap
$1.34B
Sentiment

Your view on BOEUF

Mkt Cap
$1.34B
Sentiment
Your view
BOEUF
Bonesupport Holding AB (publ)
  • Company Overview
  • FRC Research
  • Financial Data
  • Peer Comparison
  • Ownership & News
BOEUF
Company Overview

Overview

What the company does, where it operates, and who runs it.

About Bonesupport Holding AB (publ)

Industry
Medical - Instruments & Supplies
Sector
Healthcare
CEO
Torbjorn Skold
Headquarters
Scheelevägen 19, Lund, SE
Industry
Medical - Instruments & Supplies
Sector
Healthcare
CEO
Torbjorn Skold
Headquarters
Scheelevägen 19, Lund, SE
Description

Bonesupport Holding AB (publ), an orthobiologics company, develops and commercializes injectable bioceramic bone graft substitutes for the treatment of bone voids in Europe, North America, and internationally. The company provides CERAMENT Bone Void Filler, an injectable, moldable, and drillable synthetic bone void filler that includes hydroxyapatite, calcium sulfate, and the radio-contrast agent iohexol; CERAMENT G, a gentamicin injectable ceramic bone graft substitute; and CERAMENT V, a vancomycin injectable synthetic bone void filler. It also develops preclinical product candidates to promote bone regrowth focusing on trauma, revision arthroplasty, chronic osteomyelitis, revision artroplasty, and oncology, as well as bone and foot infections due to diabetes. The company was founded in 1999 and is headquartered in Lund, Sweden.

Infographics

Visual summary of the business at a glance.

FRC Research

Media

Videos and interviews covering the company.

Financial Data

Stock Data

Price chart, volume, and trading data.

Fair Value

What FRC thinks the stock is worth vs. the current price.

Financial Ratios

Profitability, returns, valuation, and leverage ratios.

Dividend Analysis

Yield, payout ratio, and dividend coverage metrics.

Earnings Analysis

EPS history, beat rate, and upcoming earnings reports.

Financial Statements

Income statement, balance sheet, and cash flow statements.

Peer Comparison

Comparables

List of peer companies in the same industry.

Ownership & News

Institutional Ownership

Which funds and firms own the stock.

Insider Trading

Recent buying and selling by company executives.

Senate Trading

U.S. Senator disclosures filed under the STOCK Act.

News

Latest headlines and market coverage.

News

Latest Market News